Charles River Laboratories International, Inc. Stock price
Equities
CRL
US1598641074
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
262.1 USD | +1.22% | -0.36% | +10.88% |
Financials (USD)
Sales 2024 * | 4.22B | Sales 2025 * | 4.53B | Capitalization | 13.46B |
---|---|---|---|---|---|
Net income 2024 * | 420M | Net income 2025 * | 525M | EV / Sales 2024 * | 3.66 x |
Net Debt 2024 * | 1.98B | Net Debt 2025 * | 1.51B | EV / Sales 2025 * | 3.3 x |
P/E ratio 2024 * |
32.3
x | P/E ratio 2025 * |
26.3
x | Employees | 21,100 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 98.21% |
Latest transcript on Charles River Laboratories International, Inc.
1 day | +1.22% | ||
1 week | -0.36% | ||
Current month | +3.12% | ||
1 month | +7.01% | ||
3 months | +14.92% | ||
6 months | +24.49% | ||
Current year | +10.88% |
Managers | Title | Age | Since |
---|---|---|---|
James Foster
CEO | Chief Executive Officer | 73 | 75-12-31 |
Flavia Pease
DFI | Director of Finance/CFO | 51 | 22-04-24 |
Birgit Girshick
COO | Chief Operating Officer | 54 | 89-03-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
C. Richard Reese
BRD | Director/Board Member | 78 | 07-12-02 |
Director/Board Member | 76 | 02-12-31 | |
Virginia Wilson
BRD | Director/Board Member | 68 | 19-09-30 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
3.05% | 1 M€ | -.--% | - | |
2.07% | 5 M€ | -1.80% | - | |
1.08% | 0 M€ | 0.00% | - | |
0.98% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-03-18 | 262.1 | +1.22% | 379,817 |
24-03-15 | 259 | -0.59% | 835,185 |
24-03-14 | 260.5 | -0.26% | 404,573 |
24-03-13 | 261.2 | -1.11% | 577,573 |
24-03-12 | 264.1 | +0.39% | 503,373 |
Delayed Quote Nyse, March 18, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+10.88% | 13.46B | |
+9.72% | 46.21B | |
+35.14% | 40.04B | |
+4.84% | 39.92B | |
-9.43% | 28.33B | |
+17.47% | 27.43B | |
-22.99% | 18.57B | |
+27.53% | 12.02B | |
-6.84% | 11.3B | |
+6.40% | 11.01B |